Defiance Daily Target 2X Long NVO ETF (NVOX)

NYSEARCA: NVOX · Real-Time Price · USD
12.49
+0.01 (0.08%)
At close: Apr 28, 2026, 4:00 PM EDT
12.43
-0.06 (-0.48%)
After-hours: Apr 28, 2026, 4:11 PM EDT
0.08%
Assets $43.86M
Expense Ratio 1.30%
PE Ratio n/a
Shares Out 3.26M
Dividend (ttm) n/a
Dividend Yield n/a
Ex-Dividend Date n/a
Payout Ratio n/a
1-Year Return -71.27%
Volume 635,978
Open 12.60
Previous Close 12.48
Day's Range 12.45 - 13.02
52-Week Low 9.23
52-Week High 72.16
Beta n/a
Holdings 12
Inception Date Dec 2, 2024

About NVOX

Fund Home Page

The Defiance Daily Target 2X Long NVO ETF (NVOX) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to deliver 2x leveraged exposure to the daily share price movement of NOVO Nordisk A/S - ADR (NVO), less fees and expenses, through derivatives like swap agreements. NVOX was launched on Dec 2, 2024 and is issued by Defiance.

Asset Class Equity
Category Trading--Leveraged Equity
Stock Exchange NYSEARCA
Ticker Symbol NVOX
ETF Provider Defiance

Top 10 Holdings

287.49% of assets
Name Symbol Weight
NOVO-NORDISK SWAP MS n/a 64.80%
US DOLLARS n/a 40.75%
OTHER ASSETS AND LIABILITIES n/a 34.32%
NOVO-NORDISK INC SWAP CANTOR n/a 25.62%
NOVO-NORDISK SWAP CLEARSTREET n/a 25.19%
NOVO-NORDISK A/S-SPONS ADR NOMURA n/a 24.37%
NOVO-NORDISK SWAP NBC-L n/a 23.12%
NOVO-NORDISK SWAP MAREX n/a 22.19%
NOVO-NORDISK SWAP BMO-L n/a 18.07%
First American Government Obligations Fund FGXXX 9.06%
View More Holdings

News

Defiance Launches NVOX, the First 2X Leveraged Single-Stock ETF on Novo Nordisk

MIAMI, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Defiance ETFs today launched NVOX, the world's first single-stock leveraged ETF for the pharmaceutical stock Novo Nordisk (NYSE: NVO). As the weight loss marke...

Other symbols: NVO
1 year ago - GlobeNewsWire